Liechtenstein - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes
Since 2014, Liechtenstein Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes rose 2.4% year on year. In 2019, the country was number 2 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes with €860.32 Per Capita. Switzerland ranked the highest with €1,048.7 Per Capita in 2019, that is a growth of 2.6% versus 2018. Latvia witnessed the best average annual growth at +7.4% per year, while Greece recorded the worst performance at -0.5% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 860.32 |
| 2018 | 835.47 |
| 2017 | 875.15 |
| 2016 | 910.55 |
| 2015 | 898.61 |
Download all data from 2013 to 2019
How does Liechtenstein rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
1,048.70 | 2019 | +2.6 % | +4.7 % | View data |
| 2 |
#2
Liechtenstein
|
860.32 | 2019 | +3.0 % | +2.4 % | View data |
| 3 |
#3
Germany
|
668.01 | 2019 | +1.7 % | +3.2 % | View data |
| 4 |
#4
Belgium
|
606.09 | 2019 | +0.1 % | +2.9 % | View data |
| 5 |
#5
Luxembourg
|
593.97 | 2019 | +0.9 % | +0.8 % | View data |